Atlas Trials

Investigation of the Atherogenic Effects of Uric Acid-modified in Endothelial Dysfunction and the the Preventional Mechanism by Anthocyanidines

Clinical trial NCT02797028 · UNKNOWN

Trial details

NCT number
NCT02797028
Sponsor
Guangzhou General Hospital of Guangzhou Military Command
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Cardiovascular Disease
Start date
2015-01-01
Primary completion
2016-10-01
Enrollment
320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.